M&A Deal Summary |
|
|---|---|
| Date | 2021-04-05 |
| Target | Kashiv Specialty Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Amneal Pharmaceuticals |
| Sellers(s) | Kashiv BioSciences |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2002 |
| Sector | Healthcare Services |
| Employees | 8,300 |
| Revenue | 2.8B USD (2024) |
Amneal Pharmaceuticals manufactures and supplies generic pharmaceuticals. The company offers prescription pharmaceutical products in various forms, including oral solids that range from tablets to capsules and soft gels; and liquid-form pharmaceuticals that range from suspensions to solutions. Amneal Pharmaceuticals was founded in 2002 and is based in Bridgewater, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 6 |
| Sector: Life Science M&A | 4 of 5 |
| Type: Divestiture M&A Deals | 1 of 2 |
| State: New Jersey M&A | 2 of 2 |
| Country: United States M&A | 5 of 6 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-12-10 |
R&S Northeas
Pulaski, Tennessee, United States AvKARE, Inc. is a licensed manufacturer and wholesaler of pharmaceuticals products. AvKARE serves the Department of Defense, Veterans Hospitals, NASA, TriCare, Dept. of Agriculture, Indian Health Services, USDA, U.S. Army, Air Force, Navy, and USMC, as well as Group Purchasing Organizations that include Amerinet, Innovatix, Health Trust Purchasing Group, IPC, Broadlane/MedAssets and Premier. AvKARE is based in Pulaski, Tennessee. |
Buy | $340M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-05 |
Saol Therapeutics - Baclofen Franchise
Roswell, Georgia, United States Saol Therapeutics' Baclofen Franchise is a pipeline product under development. Lioresal® is an intrathecal baclofen product delivered through an implantable intrathecal pump for use in the management of severe spasticity of cerebral or spinal origin for the institutional market. LYVISPAHTM is a baclofen oral granules (5, 10, and 20 mg) specialty product recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of spasticity. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 2010 |
| Sector | Life Science |
Kashiv BioSciences is a fully integrated specialty biopharmaceutical company offering next-generation drug delivery technologies and an advanced pipeline of oral & biosimilar drugs. Kashiv BioSciences was founded in 2010 and is based in Bridgewater, New Jersery.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-01-03 |
Adello Biologics
Piscataway, New Jersey, United States Adello Biologics LLC is a biotechnology company develops biosimilars. Adello Biologics was founded in 2003 and is based in Piscataway, New Jersey. |
Buy | - |
